Skip to main content
. 2013 Apr 24;2(3):360–366. doi: 10.1002/cam4.74

Figure 1.

Figure 1

Progression-free survival (upper) and overall survival (lower) among 150 patients with squamous histology who had at least stable disease after chemotherapy cycle 2 (tumor assessment made at the end of cycle 2).